Prospect Venture Partners

About The Fund

Prospect Venture Partners is a life science venture capital firm specializing in investments from seed to growth stage in biomedical companies. Founded in 1997 and based in Palo Alto, California, they are recognized for their commitment to building outstanding biomedical companies. With more than $1 billion of capital raised, Prospect Venture Partners have a robust history of supporting innovation within the life sciences sector. Their investment focus stretches across various stages of company development, starting from the initial seed phase through to more mature growth stages. The firm prides itself on partnering with exceptional teams that are committed to excellence, striving to foster developments in the biomedical field that can lead to significant advancements and improvements in healthcare outcomes. Key activities of Prospect Venture Partners include evaluating potential investment opportunities, providing financial and strategic support to their portfolio companies, and leveraging their industry expertise and network to guide biomedical ventures towards success. The firm's management team comprises individuals with a wealth of experience in the life sciences field and venture capital, including Russell Hirsch and David Schnell. They remember and honor late team member Alex Barkas for his contributions. Prospect Venture Partners manages several funds, such as Prospect Venture Partners I, II, and III, indicative of their sustained presence and experience in the sector. They maintain connections across the industry, with links to various professional platforms like LinkedIn, Crunchbase, Bloomberg, CB Insights, Palico, and Index.co. The firm's website also provides an insight into their past achievements, showcasing their involvement in the development of numerous successful companies within the life science industry. They also emphasize communication and are open to contact through their provided address and phone number for potential partnerships or inquiries.